Sébastien Dharancy
French Institute of Health and Medical Research
188 Papers
985 Citations
Sébastien Dharancy is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Medicine & Liver transplantation. The author has an hindex of 46, co-authored 147 publications. Previous affiliations of Sébastien Dharancy include university of lille.
Chat about Author
Papers
Early Liver Transplantation for Severe Alcoholic Hepatitis
Philippe Mathurin,Christophe Moreno,Didier Samuel,Jérôme Dumortier,Julia Salleron,François Durand,Hélène Castel,Alain Duhamel,Georges-Philippe Pageaux,Vincent Leroy,Sébastien Dharancy,Alexandre Louvet,Emmanuel Boleslawski,Valerio Lucidi,Thierry Gustot,Claire Francoz,Christian Letoublon,Denis Castaing,Jacques Belghiti,Vincent Donckier,François-René Pruvot,Jean-Charles Duclos-Vallée +21 more
TL;DR: Early liver transplantation can improve survival in patients with a first episode of severe alcoholic hepatitis not responding to medical therapy, and this benefit was maintained through 2 years of follow-up.
895
Liver Transplantation for Hepatocellular Carcinoma: A Model Including α-Fetoprotein Improves the Performance of Milan Criteria
Christophe Duvoux,Françoise Roudot-Thoraval,Thomas Decaens,Fabienne Pessione,Hanaa Badran,Tullio Piardi,Claire Francoz,Philippe Compagnon,Claire Vanlemmens,Jérôme Dumortier,Sébastien Dharancy,Jean Gugenheim,Pierre-Henri Bernard,René Adam,Sylvie Radenne,Fabrice Muscari,Filomena Conti,Jean Hardwigsen,Georges-Philippe Pageaux,Olivier Chazouillères,Ephrem Salamé,M.N. Hilleret,Pascal Lebray,Armand Abergel,Marilyne Debette-Gratien,Michael D. Kluger,Ariane Mallat,Daniel Azoulay,Daniel Cherqui +28 more
TL;DR: In this paper, an improved prognostic model for predicting recurrence in liver transplant candidates with hepatocellular carcinoma (HCC) was proposed by combining log(10) AFP, tumor size, and number.
872
Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients
Guillaume Lassailly,Robert Caiazzo,David Buob,Marie Pigeyre,Hélène Verkindt,Julien Labreuche,Violeta Raverdy,Emmanuelle Leteurtre,Sébastien Dharancy,Alexandre Louvet,Monique Romon,Alain Duhamel,François Pattou,Philippe Mathurin +13 more
TL;DR: Bariatric surgery induced the disappearance of NASH from nearly 85% of patients and reduced the pathologic features of the disease after 1 year of follow-up, suggesting it could be a therapeutic option for appropriate morbidly obese patients with NASH who do not respond to lifestyle modifications.
722
The Lille model: A new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids
Alexandre Louvet,Sylvie Naveau,Marcelle Abdelnour,M.-J. Ramond,Emmanuel Diaz,Laetitia Fartoux,Sébastien Dharancy,Frédéric Texier,Antoine Hollebecque,Lawrence Serfaty,Emmanuel Boleslawski,Pierre Deltenre,Valérie Canva,François-René Pruvot,Philippe Mathurin +14 more
TL;DR: In the largest cohort to date of patients with severe AH, it is demonstrated that the term “nonresponder” can now be extended to patients with a Lille score above 0.45, which corresponds to 40% of cases.
715
Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications
Pierre Nahon,Pierre Nahon,Valérie Bourcier,Richard Layese,Etienne Audureau,Carole Cagnot,Patrick Marcellin,Dominique Guyader,Hélène Fontaine,Dominique Larrey,Victor de Ledinghen,Denis Ouzan,Fabien Zoulim,Dominique Roulot,Albert Tran,Jean-Pierre Bronowicki,Jean-Pierre Zarski,Vincent Leroy,Ghassan Riachi,Paul Calès,Jean-Marie Péron,Laurent Alric,Marc Bourlière,Philippe Mathurin,Sébastien Dharancy,Jean-Frédéric Blanc,Armand Abergel,Lawrence Serfaty,Ariane Mallat,Jean-Didier Grangé,Pierre Attali,Yannick Bacq,Claire Wartelle,Thong Dao,Yves Benhamou,Christophe Pilette,Christine Silvain,Christos Christidis,Dominique Capron,Brigitte Bernard-Chabert,David Zucman,Vincent Di Martino,Vincent Thibaut,Dominique Salmon,Marianne Ziol,Angela Sutton,Stanislas Pol,Françoise Roudot-Thoraval,Gérard Thiéfin,Sophie Hillaire +49 more
TL;DR: A reduction in critical events, liver-related or not, was confirmed in the CirVir cohort, a prospective study of patients with HCV infection and compensated cirrhosis included in the ANRS cohort who achieved an SVR, to reduce overall mortality and risk of death from liver- related and non-liver-related causes.
517